Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr 27;121(16):1858-61.
doi: 10.1161/CIRCULATIONAHA.110.942383.

Thromboangiitis obliterans

Gregory Piazza  1 , Mark A Creager
Affiliations
Review

Thromboangiitis obliterans

Gregory Piazza et al. Circulation. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: None.

Figures

Figure 1
Figure 1
Pathophysiological phases of thromboangiitis obliterans.
Figure 2
Figure 2
An overall diagnostic algorithm for patients with suspected thromboangiitis obliterans.
Figure 3
Figure 3
Invasive contrast angiography in a 28-year-old female smoker with thromboangiitis obliterans, severe secondary Raynaud's phenomenon, and digital ischemia culminating in gangrene of her left index finger. Her aortic arch and proximal upper extremity arteries are free of atherosclerosis (A). However, angiography of her left hand demonstrates numerous digital occlusions and an incomplete palmar arch (B).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Olin JW. Thromboangiitis obliterans (Buerger's disease) N Engl J Med. 2000;343:864–869. - PubMed
    1. Iwai T, Inoue Y, Umeda M, Huang Y, Kurihara N, Koike M, Ishikawa I. Oral bacteria in the occluded arteries of patients with Buerger disease. J Vasc Surg. 2005;42:107–115. - PubMed
    1. Adar R, Papa MZ, Halpern Z, Mozes M, Shoshan S, Sofer B, Zinger H, Dayan M, Mozes E. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med. 1983;308:1113–1116. - PubMed
    1. Eichhorn J, Sima D, Lindschau C, Turowski A, Schmidt H, Schneider W, Haller H, Luft FC. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci. 1998;315:17–23. - PubMed
    1. Avcu F, Akar E, Demirkilic U, Yilmaz E, Akar N, Yalcin A. The role of prothrombotic mutations in patients with Buerger's disease. Thromb Res. 2000;100:143–147. - PubMed